Thomas Watkins Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Watkins.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Watkins. Thomas Watkins is Chief Executive Officer in HUMAN GENOME SCIENCES INC ($HGSI) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in Horizon Pharma plc ($HZNP).
Latest Insider Trading Transactions of Thomas Watkins
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HZNP, HGSI, VNDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Option Exercise | M | 0.00 | 11,098 | 0 | 0 | |
| Apr 30 2021 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Option Exercise | A | 0.00 | 4,223 | 0 | 4,223 | |
| Apr 30 2021 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Buy | M | 0.00 | 11,098 | 0 | 70,941 | 59.8 K to 70.9 K (+18.55 %) |
| Feb 18 2021 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | M | 7.11 | 15,000 | 106,650 | 0 | |
| Feb 18 2021 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Sell | S | 18.54 | 5,818 | 107,856 | 49,505 | 55.3 K to 49.5 K (-10.52 %) |
| Feb 18 2021 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Buy | M | 7.11 | 15,000 | 106,650 | 55,323 | 40.3 K to 55.3 K (+37.20 %) |
| Jun 15 2020 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 10.57 | 10,000 | 105,700 | 10,000 | |
| Jun 15 2020 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Grant | A | 0.00 | 5,000 | 0 | 40,323 | 35.3 K to 40.3 K (+14.16 %) |
| Jun 02 2020 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | M | 7.38 | 15,000 | 110,700 | 0 | |
| Jun 02 2020 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Sell | S | 11.50 | 9,677 | 111,286 | 35,323 | 45 K to 35.3 K (-21.50 %) |
| Jun 02 2020 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Buy | M | 7.38 | 15,000 | 110,700 | 45,000 | 30 K to 45 K (+50.00 %) |
| May 04 2020 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Option Exercise | M | 0.00 | 15,390 | 0 | 0 | |
| May 04 2020 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Option Exercise | A | 0.00 | 11,098 | 0 | 11,098 | |
| May 04 2020 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Buy | M | 0.00 | 15,390 | 0 | 59,843 | 44.5 K to 59.8 K (+34.62 %) |
| Jun 17 2019 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 15.04 | 10,000 | 150,400 | 10,000 | |
| Jun 17 2019 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Grant | A | 0.00 | 5,000 | 0 | 30,000 | 25 K to 30 K (+20.00 %) |
| May 06 2019 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Option Exercise | M | 0.00 | 15,320 | 0 | 0 | |
| May 06 2019 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Option Exercise | A | 0.00 | 15,390 | 0 | 15,390 | |
| May 06 2019 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Payment of Exercise | F | 26.54 | 4,132 | 109,663 | 44,453 | 48.6 K to 44.5 K (-8.50 %) |
| May 06 2019 | HZNP | Horizon Therapeuti ... | Watkins Thomas | Director | Buy | M | 0.00 | 15,320 | 0 | 48,585 | 33.3 K to 48.6 K (+46.05 %) |
| Jun 15 2018 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 18.30 | 10,000 | 183,000 | 10,000 | |
| Jun 15 2018 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Grant | A | 0.00 | 5,000 | 0 | 25,000 | 20 K to 25 K (+25.00 %) |
| May 07 2018 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 0.00 | 15,320 | 0 | 15,320 | |
| May 07 2018 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 13.87 | 32,161 | 446,073 | 32,161 | |
| May 07 2018 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | M | 0.00 | 14,054 | 0 | 0 | |
| May 07 2018 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Buy | M | 0.00 | 14,054 | 0 | 33,265 | 19.2 K to 33.3 K (+73.16 %) |
| May 04 2018 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | M | 4.98 | 15,000 | 74,700 | 0 | |
| May 04 2018 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Buy | M | 4.98 | 15,000 | 74,700 | 20,000 | 5 K to 20 K (+300.00 %) |
| Jun 19 2017 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 13.75 | 10,000 | 137,500 | 10,000 | |
| Jun 19 2017 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Buy | M | 0.00 | 13,953 | 0 | 19,211 | 5.3 K to 19.2 K (+265.37 %) |
| May 10 2016 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | M | 0.00 | 5,258 | 0 | 0 | |
| May 10 2016 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Buy | M | 0.00 | 5,258 | 0 | 5,258 | 0 to 5.3 K |
| May 05 2016 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 0.00 | 13,953 | 0 | 13,953 | |
| May 05 2016 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 15.23 | 23,092 | 351,691 | 23,092 | |
| Aug 21 2015 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Buy | P | 31.32 | 10,000 | 313,240 | 10,000 | 0 to 10 K |
| Jun 22 2015 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 13.03 | 15,000 | 195,450 | 15,000 | |
| May 08 2015 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 0.00 | 5,258 | 0 | 5,258 | |
| May 08 2015 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 28.53 | 8,548 | 243,874 | 8,548 | |
| Jun 24 2013 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 8.39 | 15,000 | 125,850 | 15,000 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | D | 10.47 | 1,250,000 | 13,087,500 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | D | 10.89 | 325,000 | 3,539,250 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | D | 8.23 | 360,000 | 2,962,800 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | D | 0.52 | 500,000 | 260,000 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | D | 4.92 | 500,000 | 2,460,000 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | D | 10.62 | 400,000 | 4,248,000 | 0 | |
| Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Gift | G | 14.25 | 166,075 | 2,366,569 | 0 | 166.1 K to 0 (-100.00 %) |
| Jun 18 2012 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 4.15 | 15,000 | 62,250 | 15,000 | |
| Mar 12 2012 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | A | 8.23 | 360,000 | 2,962,800 | 360,000 | |
| Jun 17 2011 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 7.11 | 15,000 | 106,650 | 15,000 | |
| Mar 21 2011 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | A | 27.10 | 400,000 | 10,840,000 | 400,000 | |
| Jan 07 2011 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 24.16 | 60,000 | 1,449,600 | 66,000 | 6 K to 66 K (+1,000.00 %) |
| Jul 13 2010 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 19.64 | 801 | 15,732 | 166,075 | 165.3 K to 166.1 K (+0.48 %) |
| Jun 07 2010 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 7.38 | 15,000 | 110,700 | 15,000 | |
| Mar 11 2010 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | A | 32.56 | 450,000 | 14,652,000 | 450,000 | |
| Aug 31 2009 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 14.78 | 15,000 | 221,700 | 15,000 | |
| Jul 02 2009 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 1.80 | 1,000 | 1,800 | 165,274 | 164.3 K to 165.3 K (+0.61 %) |
| Mar 12 2009 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | A | 0.52 | 500,000 | 260,000 | 500,000 | |
| Nov 14 2008 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 2.02 | 100,000 | 202,000 | 164,274 | 64.3 K to 164.3 K (+155.58 %) |
| Jul 02 2008 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 4.49 | 2,281 | 10,242 | 64,274 | 62 K to 64.3 K (+3.68 %) |
| May 12 2008 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 4.98 | 15,000 | 74,700 | 15,000 | |
| Mar 12 2008 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 4.93 | 10,000 | 49,300 | 61,993 | 52 K to 62 K (+19.23 %) |
| Mar 12 2008 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 4.94 | 10,000 | 49,400 | 51,993 | 42 K to 52 K (+23.81 %) |
| Mar 11 2008 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | A | 4.92 | 500,000 | 2,460,000 | 500,000 | |
| Jul 12 2007 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 7.59 | 1,993 | 15,127 | 41,993 | 40 K to 42 K (+4.98 %) |
| May 18 2007 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 19.59 | 15,000 | 293,850 | 15,000 | |
| Mar 13 2007 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | A | 10.62 | 400,000 | 4,248,000 | 400,000 | |
| Nov 14 2006 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 12.05 | 6,000 | 72,300 | 6,000 | 0 to 6 K |
| Sep 12 2006 | VNDA | Vanda Pharmaceutic ... | Watkins Thomas | Director | Option Exercise | A | 9.40 | 35,000 | 329,000 | 35,000 | |
| Sep 07 2006 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 11.14 | 30,000 | 334,200 | 40,000 | 10 K to 40 K (+300.00 %) |
| Mar 16 2006 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | A | 10.89 | 325,000 | 3,539,250 | 325,000 | |
| Jan 06 2005 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Buy | P | 11.95 | 10,000 | 119,500 | 10,000 | 0 to 10 K |
| Nov 22 2004 | HGSI | HUMAN GENOME SCIEN ... | Watkins Thomas | Chief Executive Off ... | Option Exercise | A | 10.47 | 1,250,000 | 13,087,500 | 1,250,000 |
Page: 1